nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—DCTD—eye—ocular cancer	0.00838	0.106	CbGeAlD
Cytarabine—DCTD—retina—ocular cancer	0.00831	0.105	CbGeAlD
Cytarabine—POLB—lymphoid tissue—ocular cancer	0.00733	0.0925	CbGeAlD
Cytarabine—NT5E—eye—ocular cancer	0.00649	0.0819	CbGeAlD
Cytarabine—NT5E—retina—ocular cancer	0.00643	0.0812	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—ocular cancer	0.00599	0.0756	CbGeAlD
Cytarabine—NT5E—epithelium—ocular cancer	0.00593	0.0749	CbGeAlD
Cytarabine—POLA1—retina—ocular cancer	0.00543	0.0685	CbGeAlD
Cytarabine—CDA—lymphoid tissue—ocular cancer	0.00537	0.0679	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—ocular cancer	0.00457	0.0577	CbGeAlD
Cytarabine—POLE—lymphoid tissue—ocular cancer	0.00448	0.0565	CbGeAlD
Cytarabine—DCK—retina—ocular cancer	0.00335	0.0423	CbGeAlD
Cytarabine—SLC29A1—lymphoid tissue—ocular cancer	0.00249	0.0314	CbGeAlD
Cytarabine—DCK—lymphoid tissue—ocular cancer	0.00238	0.03	CbGeAlD
Cytarabine—ABCC10—lymphoid tissue—ocular cancer	0.00227	0.0286	CbGeAlD
Cytarabine—POLE—Cell Cycle—RBBP4—ocular cancer	0.00128	0.00139	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—E2F3—ocular cancer	0.00128	0.00139	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—MYC—ocular cancer	0.00127	0.00137	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—CDK2—ocular cancer	0.00126	0.00137	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00126	0.00137	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDC25A—ocular cancer	0.00126	0.00137	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1B—ocular cancer	0.00126	0.00136	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00125	0.00136	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00125	0.00135	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00124	0.00135	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00123	0.00134	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TFDP1—ocular cancer	0.00123	0.00134	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00123	0.00133	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00122	0.00133	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00122	0.00133	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1B—ocular cancer	0.00122	0.00132	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDC25A—ocular cancer	0.00122	0.00132	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND3—ocular cancer	0.0012	0.00131	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CDKN1A—ocular cancer	0.0012	0.0013	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—E2F4—ocular cancer	0.0012	0.0013	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.0012	0.0013	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TFDP1—ocular cancer	0.00119	0.00129	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1B—ocular cancer	0.00118	0.00128	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00117	0.00128	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00117	0.00128	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PSPH—ocular cancer	0.00116	0.00126	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1A—ocular cancer	0.00116	0.00126	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—RB1—ocular cancer	0.00115	0.00125	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDK2—ocular cancer	0.00115	0.00125	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1B—ocular cancer	0.00113	0.00123	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1A—ocular cancer	0.00113	0.00122	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GNA11—ocular cancer	0.00112	0.00122	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND3—ocular cancer	0.00112	0.00121	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1B—ocular cancer	0.00111	0.00121	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PSPH—ocular cancer	0.00109	0.00119	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—E2F5—ocular cancer	0.00109	0.00119	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1A—ocular cancer	0.00109	0.00118	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDK4—ocular cancer	0.00108	0.00118	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00108	0.00117	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—RB1—ocular cancer	0.00108	0.00117	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND3—ocular cancer	0.00108	0.00117	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—E2F4—ocular cancer	0.00107	0.00116	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYBL2—ocular cancer	0.00107	0.00116	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1B—ocular cancer	0.00107	0.00116	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00106	0.00116	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00106	0.00115	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RBL1—ocular cancer	0.00105	0.00114	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—E2F2—ocular cancer	0.00105	0.00114	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1A—ocular cancer	0.00105	0.00114	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GNAQ—ocular cancer	0.00105	0.00114	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—ocular cancer	0.00104	0.00113	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00104	0.00113	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—RB1—ocular cancer	0.00104	0.00113	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1B—ocular cancer	0.00103	0.00112	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1A—ocular cancer	0.00103	0.00112	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00102	0.00111	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00102	0.00111	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00102	0.00111	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CCND1—ocular cancer	0.00102	0.0011	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00101	0.0011	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00101	0.00109	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1A—ocular cancer	0.000984	0.00107	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCND1—ocular cancer	0.000982	0.00107	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—EP300—ocular cancer	0.000978	0.00106	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000969	0.00105	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000968	0.00105	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RBL2—ocular cancer	0.000965	0.00105	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000956	0.00104	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1A—ocular cancer	0.00095	0.00103	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000947	0.00103	CbGpPWpGaD
Cytarabine—POLA1—S Phase—RB1—ocular cancer	0.000942	0.00102	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000935	0.00102	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00093	0.00101	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000923	0.001	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000912	0.00099	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—E2F3—ocular cancer	0.000911	0.000989	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RBBP4—ocular cancer	0.000911	0.000989	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000898	0.000975	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CDKN1B—ocular cancer	0.000895	0.000971	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000893	0.00097	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000882	0.000958	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000875	0.00095	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—MYC—ocular cancer	0.000868	0.000942	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDC25A—ocular cancer	0.000866	0.000941	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000859	0.000932	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000854	0.000927	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—MYC—ocular cancer	0.000852	0.000925	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.000849	0.000922	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TFDP1—ocular cancer	0.000847	0.00092	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1B—ocular cancer	0.000839	0.000911	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK6—ocular cancer	0.000831	0.000903	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000831	0.000902	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CDKN1A—ocular cancer	0.000826	0.000897	CbGpPWpGaD
Cytarabine—POLD1—S Phase—MYC—ocular cancer	0.000816	0.000886	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—CDKN1B—ocular cancer	0.000808	0.000878	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000806	0.000876	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK6—ocular cancer	0.000803	0.000872	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000799	0.000868	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000799	0.000868	CbGpPWpGaD
Cytarabine—POLE—S Phase—MYC—ocular cancer	0.000788	0.000856	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1A—ocular cancer	0.000774	0.000841	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000772	0.000838	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000772	0.000838	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND3—ocular cancer	0.000768	0.000834	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000762	0.000828	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—CDKN1A—ocular cancer	0.000746	0.00081	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000741	0.000804	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDKN1B—ocular cancer	0.000734	0.000797	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.000733	0.000796	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000731	0.000794	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000717	0.000778	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—HDAC1—ocular cancer	0.000715	0.000776	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND2—ocular cancer	0.000715	0.000776	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CCND1—ocular cancer	0.0007	0.00076	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000692	0.000752	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND2—ocular cancer	0.00069	0.00075	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—HDAC1—ocular cancer	0.00069	0.00075	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000681	0.00074	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDKN1A—ocular cancer	0.000677	0.000735	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000658	0.000714	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00065	0.000706	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNA11—ocular cancer	0.000646	0.000701	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2B—ocular cancer	0.000641	0.000696	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00064	0.000695	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000635	0.00069	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000628	0.000682	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2B—ocular cancer	0.000619	0.000672	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—ocular cancer	0.000618	0.000672	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000608	0.00066	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.000605	0.000657	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000602	0.000654	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNAQ—ocular cancer	0.0006	0.000652	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNA11—ocular cancer	0.000591	0.000642	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—E2F1—ocular cancer	0.000588	0.000639	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK6—ocular cancer	0.000572	0.000621	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—E2F1—ocular cancer	0.000568	0.000617	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000567	0.000616	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000565	0.000614	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—ocular cancer	0.000561	0.00061	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00055	0.000597	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00055	0.000597	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNAQ—ocular cancer	0.000549	0.000596	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000548	0.000595	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000536	0.000582	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.000522	0.000567	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000521	0.000566	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000518	0.000562	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000516	0.00056	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK2—ocular cancer	0.000507	0.000551	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000493	0.000536	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000492	0.000534	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND2—ocular cancer	0.000492	0.000534	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—HDAC1—ocular cancer	0.000492	0.000534	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK2—ocular cancer	0.00049	0.000532	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK4—ocular cancer	0.000479	0.000521	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000476	0.000517	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RB1—ocular cancer	0.000466	0.000506	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK4—ocular cancer	0.000463	0.000503	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000453	0.000492	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000453	0.000492	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RB1—ocular cancer	0.00045	0.000489	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2B—ocular cancer	0.000441	0.000479	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PSPH—ocular cancer	0.000434	0.000471	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000429	0.000466	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RB1—ocular cancer	0.000417	0.000453	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—E2F1—ocular cancer	0.000405	0.00044	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PSPH—ocular cancer	0.000404	0.000439	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RB1—ocular cancer	0.000403	0.000437	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000395	0.000429	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000394	0.000428	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00039	0.000424	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—EP300—ocular cancer	0.000376	0.000408	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000369	0.000401	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNA11—ocular cancer	0.000366	0.000398	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000363	0.000394	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MDM2—ocular cancer	0.000355	0.000386	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000351	0.000381	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK2—ocular cancer	0.000349	0.000379	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000346	0.000376	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNA11—ocular cancer	0.000345	0.000374	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MDM2—ocular cancer	0.000343	0.000373	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNAQ—ocular cancer	0.000341	0.00037	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000335	0.000364	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000334	0.000363	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK4—ocular cancer	0.00033	0.000358	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1B—ocular cancer	0.000325	0.000352	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000324	0.000352	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000323	0.000351	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000321	0.000349	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RB1—ocular cancer	0.000321	0.000348	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNAQ—ocular cancer	0.00032	0.000348	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—EP300—ocular cancer	0.000319	0.000346	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1B—ocular cancer	0.000313	0.00034	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—ocular cancer	0.00031	0.000336	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—EP300—ocular cancer	0.000308	0.000334	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1A—ocular cancer	0.000299	0.000325	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—ocular cancer	0.000299	0.000325	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000295	0.00032	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1A—ocular cancer	0.000289	0.000314	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RB1—ocular cancer	0.000287	0.000312	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—EP300—ocular cancer	0.000285	0.000309	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—ocular cancer	0.000278	0.000302	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—EP300—ocular cancer	0.000275	0.000299	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000275	0.000298	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000274	0.000297	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—ocular cancer	0.000268	0.000291	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.00025	0.000271	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—ocular cancer	0.000248	0.00027	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MDM2—ocular cancer	0.000245	0.000266	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—ocular cancer	0.00024	0.00026	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000238	0.000259	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.00023	0.00025	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—ocular cancer	0.000227	0.000247	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MDM2—ocular cancer	0.000226	0.000245	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1B—ocular cancer	0.000223	0.000243	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—EP300—ocular cancer	0.000219	0.000238	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—EP300—ocular cancer	0.000216	0.000234	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—ocular cancer	0.000213	0.000231	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MDM2—ocular cancer	0.00021	0.000229	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1A—ocular cancer	0.000206	0.000224	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—ocular cancer	0.000204	0.000221	CbGpPWpGaD
Cytarabine—CDA—Metabolism—EP300—ocular cancer	0.000197	0.000214	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—ocular cancer	0.000197	0.000214	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—EP300—ocular cancer	0.000196	0.000213	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—ocular cancer	0.000191	0.000208	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—ocular cancer	0.000171	0.000186	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000162	0.000176	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000151	0.000164	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PSPH—ocular cancer	0.000146	0.000158	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—ocular cancer	0.00014	0.000152	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNA11—ocular cancer	0.000136	0.000148	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—ocular cancer	0.00013	0.000142	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNA11—ocular cancer	0.000127	0.000138	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNAQ—ocular cancer	0.000127	0.000138	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—ocular cancer	0.000124	0.000135	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—EP300—ocular cancer	0.000122	0.000133	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—ocular cancer	0.000119	0.00013	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNAQ—ocular cancer	0.000118	0.000128	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—ocular cancer	0.000115	0.000125	CbGpPWpGaD
Cytarabine—DCK—Metabolism—EP300—ocular cancer	0.000115	0.000125	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—ocular cancer	7.4e-05	8.03e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—ocular cancer	6.96e-05	7.55e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNA11—ocular cancer	4.59e-05	4.99e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EP300—ocular cancer	4.56e-05	4.95e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNAQ—ocular cancer	4.27e-05	4.64e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EP300—ocular cancer	4.25e-05	4.61e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—ocular cancer	2.75e-05	2.99e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—ocular cancer	2.57e-05	2.79e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EP300—ocular cancer	1.53e-05	1.67e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—ocular cancer	9.27e-06	1.01e-05	CbGpPWpGaD
